086040 — Biotoxtech Co Income Statement
0.000.00%
Last trade - 00:00- KR₩45bn
- KR₩86bn
- KR₩41bn
- 11
- 38
- 35
- 14
Annual income statement for Biotoxtech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 26,429 | 32,717 | 37,292 | 32,631 | 41,341 |
| Cost of Revenue | |||||
| Gross Profit | 6,436 | 10,546 | 12,480 | 1,899 | 2,557 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 25,891 | 28,086 | 36,312 | 40,855 | 49,859 |
| Operating Profit | 537 | 4,632 | 979 | -8,224 | -8,517 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3,245 | 6,485 | -644 | -11,833 | -8,822 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,367 | 6,698 | 64.7 | -8,950 | -12,657 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 2,614 | 7,114 | 2,725 | -4,878 | -6,427 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2,614 | 7,114 | 2,725 | -4,878 | -6,427 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 180 | 446 | 82.9 | -314 | -419 |
| Dividends per Share |